SCHEMBL2004123

SCHEMBL2004123

Cc1c(CC(=O)O)c2cc(O)ccc2n1Cc1cccc(O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 11/20 0.71
PLA2G1B P04054 1/20 0.63
MAPT P10636 3/20 0.59
PKM P14618 3/20 0.59
GAA P10253 2/20 0.59
ALDH1A1 P00352 2/20 0.59
PTGDR2 Q9Y5Y4 1/20 0.58
LMNA P02545 3/20 0.57
KDM4E B2RXH2 2/20 0.57
THRA P10827 1/20 0.55
THRB P10828 1/20 0.55
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2C9 P11712 2/20 0.55
TSHR P16473 2/20 0.55
CYP2C19 P33261 2/20 0.55
PMP22 Q01453 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
RGS12 O14924 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5437216 0.93 PLA2G2A (0.82) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2007900 0.91 PLA2G2A (0.63) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2003130 0.90 PLA2G2A (0.71) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2004243 0.89 PLA2G2A (0.72) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2002826 0.86 PLA2G2A (0.72) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL6025562 0.85 MAPT (0.73) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2001710 0.85 PLA2G2A (0.52) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL3000875 0.84 PTGS2 (0.74) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2006571 0.84 PLA2G2A (0.59) PLA2G2APLA2G1BMAPTPKMGAA
SCHEMBL2001561 0.83 PLA2G2A (0.64) PLA2G2APLA2G1BMAPTPKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 PLA2G2A 3285/4885PLA2G1B 2354/4885MAPT 997/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT PLA2G2A 326/4885PLA2G1B 220/4885MAPT 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.